As of April 16, 2025, Keros Therapeutics (KROS) has a market cap of $0.53 billion USD. According to our data, Keros Therapeutics is ranked No.5893 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.53 B |
-17.20%
|
Dec 31, 2024 | $0.64 B |
-60.19%
|
Dec 29, 2023 | $1.61 B |
-17.20%
|
Dec 30, 2022 | $1.95 B |
-17.93%
|
Dec 31, 2021 | $2.37 B |
-17.05%
|
Dec 31, 2020 | $2.86 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() FibroGen
FGEN
|
$29.89 M |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.52 B |
0.000 M
|
![]() Netherlands
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
Market Cap | = | KROS Stock Price | * | KROS Shares Outstanding |
= | $13.09 | * | 40.56 M | |
= | $0.53 B |